Miostan
YK-11 – 7.5mg (2 click)
130 clicks/bottle
1 click/3.75mg
🧬 Myostatin Modulator | Steroidal SARM Derivative
💊 Oral Capsule | Research Compound
Description
YK-11 is a synthetic compound structurally related to steroidal SARMs, studied for its potential to modulate myostatin expression and promote enhanced muscle cell differentiation through androgen receptor interaction.
🧪 Form and Storage
– 💊 Form: Oral capsules or liquid solution in sealed container
– 🧊 Storage: Store at 15–25°C, protected from moisture and direct light
– 🕒 Stability: Stable at controlled room temperature
– ⚠️ Keep container tightly closed
– 🔁 Intended for once- or split-daily administration in research settings
🔬 What is YK-11?
YK-11 is a synthetic compound that binds to the androgen receptor (AR) and is reported in limited in-vitro research to increase follistatin expression, a protein that inhibits myostatin — a regulatory factor that limits muscle growth.
By potentially suppressing myostatin signaling and activating AR pathways, YK-11 may influence muscle cell differentiation and hypertrophy beyond typical SARM activity. However, available data are largely limited to cell-based studies, and human research is minimal.
It remains an experimental research compound and is not approved for medical or therapeutic use.
✅ Potential Research Benefits of YK-11
● May modulate myostatin signaling pathways
● Promotes follistatin expression (in vitro data)
● Supports muscle cell differentiation
● Exhibits anabolic receptor activity
● May enhance strength and hypertrophy potential in theory
● Potential relevance in muscle-wasting research models
⚠️ Possible Side Effects
● Testosterone suppression (theoretical and anecdotal reports)
● Joint discomfort or dryness
● Lipid profile alterations
● Possible hepatotoxicity risk (limited data)
● Extremely limited human safety research
● Experimental status — not FDA approved
📏 Dosage Guidelines (Research Context)
● Research dosage: 5–10 mg per day
● Cycle duration: 4–8 weeks
● Route of administration: Oral
● Post-cycle hormonal evaluation recommended due to suppressive potential
🧼 Best Practices
● Conduct baseline and follow-up blood panels
● Monitor liver enzymes and lipid markers
● Maintain consistent dosing timing
● Avoid stacking with other suppressive agents without monitoring
● Discontinue immediately if adverse reactions occur
🧠 Lifestyle and Dietary Considerations
● Maintain a structured resistance training protocol
● Ensure adequate protein intake (1.6–2.2 g/kg)
● Prioritize joint support nutrients (collagen, omega-3)
● Maintain 7–9 hours of sleep for recovery optimization
● Avoid alcohol and additional hepatotoxic compounds
💡 YK-11 is a highly experimental myostatin-modulating research compound with limited human data.
Use within controlled research environments only, with strict monitoring and risk assessment.
